The trial has enrolled 99 subjects from various centres globally to assess the efficacy and safety of the therapy.

Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

Updated guidance offers evidence-based strategies to optimize the diagnosis and treatment of non-metastatic upper tract ...

ASCO 2025 phase 1b/2 study assessing 9MW2821, nectin-4 antibody drug conjugate, toripalimab in treatment-naïve patients, locally advanced or metastatic urothelial carcinoma.

Bladder cancer may be scary but it will help to know that depending on the stage of cancer treatment will help control or ...

A new review was published in Volume 16 of Oncotarget on June 17, 2025, titled "Optimizing enfortumab vedotin plus ...

According to the latest study from BCC Research, "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic ...

ASCO 2025 interim analysis from the JAVELIN Bladder Medley phase 2 trial, avelumab + sacituzumab govitecan, avelumab monotherapy, first-line maintenance treatment in patients with advanced urothelial ...

Upper urinary tract transitional cell carcinoma (TCC) refers to malignant changes of the transitional epithelial cells lining the urinary tract from the renal calyces to the ureteral orifice.

'And Just Like That' season 3 explores Charlotte and Harry's marriage after Harry reveals his shocking prostate cancer diagnosis ...